Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

BLCM

Bellicum Pharmaceuticals (PK) (BLCM)

Bellicum Pharmaceuticals Inc (PK)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:BLCM

1

Data	Hora	Fonte	Título	Código	Companhia
01/03/2024	17:13	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	USOTC:BLCM	Bellicum Pharmaceuticals Inc (PK)
27/02/2024	02:18	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	USOTC:BLCM	Bellicum Pharmaceuticals Inc (PK)
21/02/2024	18:07	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:BLCM	Bellicum Pharmaceuticals Inc (PK)
14/11/2023	18:24	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:BLCM	Bellicum Pharmaceuticals Inc (PK)
06/02/2020	19:29	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BLCM	Bellicum Pharmaceuticals Inc (PK)
04/02/2020	16:26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BLCM	Bellicum Pharmaceuticals Inc (PK)
29/01/2020	18:57	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:BLCM	Bellicum Pharmaceuticals Inc (PK)
24/01/2020	19:19	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:BLCM	Bellicum Pharmaceuticals Inc (PK)
05/12/2019	18:13	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:BLCM	Bellicum Pharmaceuticals Inc (PK)
05/12/2019	18:11	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:BLCM	Bellicum Pharmaceuticals Inc (PK)
25/11/2019	18:45	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:BLCM	Bellicum Pharmaceuticals Inc (PK)